News
Hosted on MSN10mon
Scientists offer strong carbon plastics for aviation - MSNEmployees of the Institute of Chemistry of Kazan Federal University and the Kazan National Research Technical University have produced especially strong carbon plastics based on phosphate binders ...
CMS intends to include the agent in the ESRD prospective payment system effective Jan. 1, 2025, but unlike calcimimetics and phosphate binders, tenapanor will have its own transitional drug add-on ...
Based on a survey conducted in 2022, Nephrologists stated that the greatest unmet need in the treatment of hyperphosphatemia with phosphate binders is a lower pill burden and better patient ...
Factors associated with phosphate control. Three quarters (n=84) of the patients were prescribed phosphate binders.There was no significant association between phosphate control and being ...
Hosted on MSN1mon
DaVita reiterates 2025 guidance amid cyber incident and expects phosphate binders to contribute at upper end of range - MSNManagement now expects the full-year operating income contribution from phosphate binders to be at the upper end of the previously guided range of zero to positive $50 million, citing a higher ...
Oral phosphate binders may decrease the risk for osteoporotic fracture in patients starting dialysis, a new study finds. In a retrospective study of 69,368 patients initiating dialysis, the risk ...
An oral drug, tenapanor is specifically indicated as an add-on therapy for adult patients with an inadequate response to phosphate binders or for those who are intolerant of the drugs, and marks ...
Based on a survey conducted in 2022, Nephrologists stated that the greatest unmet need in the treatment of hyperphosphatemia with phosphate binders is a lower pill burden and better patient ...
DaVita reiterates 2025 guidance amid cyber incident and expects phosphate binders to contribute at upper end of range. May 12, 2025 9:42 PM ET DaVita Inc. (DVA) Stock AI-Generated Earnings Calls ...
Patient-Reported Outcomes Data Patient-reported outcomes from the open-label Phase 2 UNI-OLC-201 clinical trial compared patients’ satisfaction with their pre-trial phosphate binders versus OLC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results